Homozygosity for the hemoglobin (Hb) S mutation (HbSS, sickle cell anemia) results in hemoglobin polymerization under hypoxic conditions leading to vaso-occlusion and hemolysis. Sickle cell anemia affects 1:500 African Americans and is a strong risk factor for kidney disease, although the mechanisms are not well understood. Heterozygous inheritance (HbAS; sickle cell trait) affects 1:10 African Americans and is associated with an increased risk for kidney disease in some reports. Using transgenic sickle mice, we investigated the histopathologic, ultrastructural, and gene expression differences with the HbS mutation. Consistent with progressive glomerular damage, we observed progressively greater urine protein concentrations ( 
INTRODUCTION
The sickle hemoglobin (HbS) mutation β-globin gene (HBB E6V ) has undergone selection by providing protection from Plasmodium falciparum malaria. 1 This mutation is observed in 10% of African Americans and can reach a prevalence of up to 40% in certain regions of subSaharan Africa, the Middle East, and India. 2 Inheritance of the HbS mutation in the homozygous state (HbSS, sickle cell anemia) is associated with hemoglobin polymerization under hypoxic conditions causing red blood cell deformity, extravascular and intravascular hemolysis, vaso-occlusion, and many acute and chronic complications. The kidneys are among the most commonly affected organ systems. Chronic kidney disease (CKD) occurs in up to 60% of HbSS adults, 3, 4 and is a consistent predictor for early mortality. [5] [6] [7] Although renal biopsy tissues from HbSS patients are infrequently available, small studies have demonstrated glomerular hypertrophy, membranoproliferative glomerulopathy, focal and segmental glomerulosclerosis, and hemosiderin deposition in the proximal tubules. [8] [9] [10] [11] [12] The mechanisms for how the nephrons are damaged and how CKD develops in sickle cell anemia are poorly understood but may include hyperfiltration, ischemiareperfusion injury, vasculopathy, and hypertension. 13 Heterozygous inheritance of the HbS mutation (HbAS, sickle cell trait) is also associated with renal manifestations. These include defects in urine concentrating ability, an increased prevalence of hematuria, and a higher risk for renal medullary cancer than the general population. 14 Large population studies have recently demonstrated that sickle cell trait is also associated with an increased risk for albuminuria, CKD, and end-stage renal disease (ESRD) in African Americans. 15, 16 Consistent findings for the association of HbAS with CKD were demonstrated in Hispanics and Latinos with a Caribbean background 17 but not in a cohort of adults from the Democratic Republic of Congo. 18 Renal tissue of HbAS patients has been rarely analyzed but glomerular enlargement, mesangial proliferation, and iron deposition may also occur. 10 The pathophysiological mechanisms for how inheritance of HbAS leads to CKD are also poorly understood.
Transgenic mice harboring the HbS mutation have been developed and may improve our understanding of the pathophysiology occurring in the kidneys. Similar to what has been observed in humans, HbSS mice have higher urine protein concentrations compared to HbAA mice and frequently demonstrate glomerulosclerosis and membranoproliferative glomerulonephritis-like lesions. [19] [20] [21] The HbSS mice also demonstrate glomeruli that are hypertrophied with increased cellularity, thickened glomerular basement membrane (GBM), and mesangial expansion while the tubules have increased iron deposition, atrophy, and increased basement membrane thickening. 19, [21] [22] [23] Hemizygous mice that express both mouse and human hemoglobin have been examined as a model for HbAS. 24, 25 These studies have demonstrated enlarged glomeruli with increased cellularity, thickened GBM, and tubular degeneration in the hemizygous mice compared to control mice, although the hemizygous model is limited by the presence of mouse α chains which can interfere with HbS polymerization as effectively as human γ chains do. 26 To date, a comprehensive evaluation of urine, histopathology, electron microscopy, and gene expression changes occurring in the kidney of HbAA, HbAS, and HbSS transgenic knockout mice exclusively expressing human α-, β-, and γ-globin has not been reported.
We conducted a study of transgenic sickle mice to determine whether progressive renal cortical damage is observed in HbAA, HbAS, and HbSS mice. We also sought to identify genes that are differentially expressed AT A GLANCE COMMENTARY Saraf SL, et al.
Background
Sickle cell anemia (HbSS) and sickle cell trait (HbAS) are both associated with an increased risk for kidney disease, although the mechanisms are not well understood.
Translational Significance
We observed progressive glomerular and tubular damage, determined by increasing urine protein concentrations, histopathologic changes, and ultrastructural abnormalities, in transgenic HbAS and HbSS mice. Gene expression studies identified the differential expression of several candidate genes with inheritance of the HbS mutation and pathway analysis highlighted increased gene enrichment of several pathways for future investigation in sickle cell trait and sickle cell anemia-related kidney disease.
in the renal cortex to highlight functional pathways by which the kidneys may be injured in sickle cell trait and sickle cell anemia. Blood and urine were collected on the day of animal sacrifice. Automated complete blood counts were obtained using the Advia 120 Hematology System (Siemens, Erlangen, Germany). Urine protein concentration was measured by the Bio-Rad dye method (Bio-Rad Laboratories Inc, Hercules, Calif.), and urine creatinine concentration by the Jaffé reaction, using the picric acid reagent supplied by Sigma Chemical Co (Saint Louis, Mo.). Before harvesting the kidneys, the mice were perfused with PBS until clear fluid was returning to the heart. The kidneys were immediately weighed and the renal cortex was processed for histology, electron microscopy, and gene expression studies.
METHODS
Histopathology. Masson trichrome, hemotoxylin and eosin, and periodic acid-Schiff stained sections of the kidney were evaluated by renal pathologists blinded to the genotype of each specimen. Mesangial expansion was defined as increased matrix with increased mesangial cell number (>5 nuclei/mesangium). Mesangial expansion was graded based on the proportion of glomeruli per slide affected as follows: focal process if <50% involvement or a diffuse process if ≥50% involvement. The perimeters of randomly selected glomeruli were measured using NanoZoomer Whole Slide Imaging (Hamamatsu Photon Imaging, Japan) and the nuclei per glomerulus were manually counted. Glomerular enlargement was defined as a glomerular perimeter >300 µM, which represented the upper quartile of measured glomeruli.
Electron microscopy. Renal cortical tissue was dissected into 1-mm sections and samples were processed by the UIC, Electron Microscopy Service Core for transmission electron microscopy (TEM) imaging. Kidney tissues were fixed in buffered 2% p-formaldehyde + 2.5% glutaraldehyde (pH, 7.2), rinsed with 0.1M sodium phosphate buffer, post-fixed with 1% osmium tetroxide, and dehydrated using an ascending series of ethanol solutions through 100%. They were then embedded in LX112 epoxy resin and polymerized at 60°C for 2-3 days. Toluidine blue stained semi-thin sections (0.5-1 µm) were taken to identify areas of interest, after which thin sections (70-80 nm) were collected and stained with uranyl acetate and lead citrate, respectively. Specimens were examined using a JEOL JEM-1220 transmission electron microscope. Digital images were acquired using an Erlangshen ES1000W model 785 CCD camera and Digital Micrograph software 1.7.1. Electron micrographs of HbAA, HbAS, and HbSS mice were obtained and examined for glomerular and tubular differences between the 3 genotypes.
Gene expression. Renal cortical tissue was immediately frozen in liquid nitrogen after dissection. The RNA was extracted and processed by the UIC, Core Genomics Facility. A total of 15 samples (5 samples per genotype; all female and 9 months of age) were collected. RNA purification, labeling, and hybridization were performed independently for each sample. An Affymetrix Mouse Gene Array 2.0 (Thermo Fisher Scientific, Waltham, Mass.) was employed for the study. This single array provides coverage of over 28,000 coding transcripts and >7000 long intergenic noncoding transcripts. Total cellular RNA was isolated with the use of RNeasy kit (Qiagen, Valencia, Calif.) according to the manufacturer's protocol. RNA quality control was performed with the use of automated electrophoresis system TapeStation (Agilent, Santa Clara, Calif.). Labeling reactions and hybridizations were carried out according to the Whole Transcript (WT) Plus Target labeling protocol (Thermo Fisher Scientific, Waltham, Mass.). One hundred nanogram of total RNA was used in each labeling reaction. The resulting labeled and fragmented ss-cDNA target was hybridized to the arrays. To minimize the batch-tobatch array variation, all hybridizations were performed with arrays from the same manufacturing lot. Hybridizations were followed by binding to a streptavidinconjugated fluorescent marker. Detection of bound probe was achieved following laser excitation of the fluorescent marker and scanning of the resultant emission spectra using a scanning confocal laser microscope (Thermo Fisher Scientific). Signal acquisition was performed using the Affymetrx GeneChip Command Console suite.
Probe level summarization of files was performed using Partek Genomics Suite (Partek, Saint Louis, Mo.). The Robust Multi-array Average method was used to background correct and normalize hybridization signal intensities across all collected samples. 27 Experimental groups of samples were compared using an additive model by linear regression to identify genes that are differentially expressed with inheritance of the HbS mutation. Raw and false discovery rate (FDR) corrected P-values following the Benjamini-Hochberg procedure of differential expression were calculated. Differentially expressed transcripts were initially annotated according to the latest release of Affymetrix NetAffx Analysis Center. This webbased resource facilitates for each individual transcript biological annotation and functional classification according to GO (http://www.geneontology.org), KEGG (http://www.genome.ad.jp/kegg), and Entrez Gene (http:// www.ncbi.nlm.nih.gov) databases. We used the DAVID bioinformatics resources 28 to develop gene enrichment pathway analysis using the 1029 genes that were differentially expressed. Hypoxia hallmark genes were obtained at: http://www.broadinstitute.org/gsea/msigdb/ cards/HALLMARK_HYPOXIA and mapped to the orthologous genes in the mouse. Pathways with a Benjamini-adjusted P-value ≤0.01 were considered statistically significant.
Statistical methods. Comparisons between each genotype were performed using Student's t test for linear variables and chi-square analysis for categorical variables. To determine whether inheritance of the HbS gene (HbAA to HbAS to HbSS) caused incremental damage, we used the test for linear trend for linear variables and Cochran's test of linear trend for categorical variables. The renal pathologists were blinded to the genotype of each specimen, and all mice were considered as a unique, independent variable. Analyses were performed using Systat 13 (Systat Software Corporation, San Jose, California, USA) and mean values ± standard error of the mean are provided.
RESULTS
We conducted studies on 56 age-and gender-matched transgenic mice greater than 6 months of age who were in relatively healthy condition (HbAA: n = 13, HbAS: n = 28; HbSS: n = 15). Baseline complete blood counts demonstrated that the HbSS mice had more severe hemolysis, reflected by lower hemoglobin concentrations and higher reticulocyte percentages, a higher white blood cell count, and a lower platelet count compared to HbAS and HbAA mice (Fig 1) . We observed progressively higher urine protein concentrations (P = 0.03 for trend) (Fig 2) in HbAA, HbAS, and HbSS mice. Expressed as the ratio to body weight, HbSS mice had greater kidney masses (15.9 ± 0.6 mg/g body weight) compared to HbAS and HbAA mice (12.6 ± 0.4 and 12.9 ± 0.6 mg/g body weight, respectively; P ≤ 0.002).
Histopathology. When grading the degree of mesangial expansion, a focal process (<50% of glomeruli/slide affected) was observed in HbAA and more so in HbAS mice, whereas a focal to a global process (≥50% of glomeruli/slide affected) was observed in HbSS mice ( Fig 3) . Hemosiderin staining was moderately increased in the glomeruli and markedly increased in the tubules of the HbSS mice vs the HbAS and HbAA mice. Progressively greater proportions of enlarged glomeruli were observed in HbAA (15%), HbAS (31%), and HbSS (58%) transgenic mice (P = 0.002 for trend) (Fig 4A) . Similarly, the number of nuclei per glomerulus progressively increased in HbAA (35.7 ± 1.7), HbAS (37.0 ± 1.7), and HbSS (41.7 ± 1.7) mice (P = 0.01 for trend) (Fig 4B) . Electron microscopy. The HbAA mice had predominantly intact foot processes and fairly uniform glomerular and tubular basement membranes (Fig 5, A and B) . Mesangial areas were also uniformly populated with cells and matrix. In comparison, the HbAS mice had focal effacement of foot processes along with variably thickened GBMs and segmental subendothelial electron lucent widening. One of the 2 examined glomeruli demonstrated segmental areas of early basement membrane reduplication with mesangial interposition (Fig 5, C) . The HbAS mice also had focal microvillous blunting and shortening of the tubular brush borders (Fig 5, D) . Similar, but more pronounced changes were observed in the HbSS mice, with both examined glomeruli showing easily identifiable areas of subendothelial electron-lucent widening and more pronounced segmental areas of early basement membrane reduplication with mesangial interposition (Fig 5, E) . The HbSS mice also had brush borders with focal marked attenuation of microvilli (Fig 5, F) .
Gene expression. Using an additive model with FDR <0.01, 1029 genes were differentially expressed in the kidney cortex with inheritance of the HbS mutation. The 10 genes with the strongest β-values are provided in Table I . Other genes that were differentially expressed include those that are involved in maintaining the glomerular filtration barrier (PODXL, β 0.59, FDR 0.009) or have been implicated in diabetic nephropathy (ELMO1, β 0.28, FDR 0.003; FRMD3, β −0.11, FDR 0.009). Gene enrichment pathway analysis of the differentially expressed genes identified that focal adhesion (3.4-fold enrichment), extracellular matrixreceptor interaction (5.0-fold enrichment), and axon guidance (3.8-fold enrichment) were upregulated with inheritance of the HbS mutation (Table II) . When focusing on hypoxia hallmark genes, we identified 6 additional genes differentially expressed with inheritance of the HbS mutation (FDR <0.01) ( Table III) . The MYH9 gene, which co-segregates with APOL1 and has been implicated in kidney disease, 29 was identified as a hypoxia gene differentially expressed with inheritance of the HbS mutation (β 0.59, FDR 0.01). APOA1 encodes the major structural protein of high-density lipoprotein particles, including the APOL1-trypanasome lytic factor complex, 30 and was also differentially expressed with the HbS mutation (β −0.25, FDR 0.003). We did not observe significant changes in the expression of Hp, the main scavenger of cell-free hemoglobin in circulation, with the HbS mutation (FDR 0.5).
DISCUSSION
Using a transgenic sickle mouse model, we observed progressive glomerular changes with inheritance of HbAS and HbSS. Urine protein concentration, glomerular hypertrophy, and glomerular cellularity progressively increased in HbAS and HbSS mice. Ultrastructural studies supported our findings of progressive glomerular damage with HbAS and HbSS, demonstrating incremental degrees of podocyte foot process effacement and glomerular basement membrane reduplication with mesangial interposition. In addition, progressive tubular damage, reflected by incremental brush border microvillous abnormalities by TEM, was observed. Gene expression profiling of the kidney cortex identified (1) several genes involved in plausible pathways for sickle cell trait and sickle cell anemia-related nephropathy, (2) genes implicated in focal segmental glomerulosclerosis or diabetic nephropathy, and (3) a gene enrichment pathway analysis emphasizing focal adhesion, extracellular matrix-receptor interactions, and axon guidance with inheritance of the HbS mutation. Initial reports demonstrated that HbAS was twice as common in African Americans with ESRD, 31 although a subsequent study did not find an association between HbAS and ESRD after adjusting for the APOL1 G1/G2 risk variants. 32 More recently, large cohort studies of African Americans have shown that HbAS is associated with a 1.8-fold increased risk for incident CKD 15 and a 2.0-fold increased risk for developing ESRD, 16 independent of APOL1 risk variant status. The association of HbAS and CKD has also been demonstrated in a cohort of Caribbean background 17 but not in an adult cohort from the Democratic Republic of Congo. 18 The evaluation of glomerular and tubular changes in HbAS patients has been less frequently reported but cortical infarcts with sickled red blood cells plugging glomerular capillaries was observed in a case report of an HbAS patient with nephrotic syndrome, and moderate increases in glomerular size and tubular atrophy were observed in a case series of 10 HbAS patients. 10, 33 To our knowledge, this is the first report describing progressive histopathologic and ultrastructural abnormalities with inheritance of the HbS mutation. Also unique to our study is the histopathologic and ultrastructural evidence that glomerular and tubular damage is occurring in HbAS kidneys, providing support to the epidemiologic findings that HbAS is a risk factor for CKD.
Among our top 10 differentially expressed genes, we identified several candidate genes with plausible mechanisms for kidney disease in sickle cell trait and sickle cell anemia. AKR1C18, which is involved in prostaglandin metabolism, was downregulated in HbAS and HbSS mice. This is particularly interesting because prostaglandins have been implicated in the hyperfiltration of sickle cell anemia, 34 progressively higher proportions of Congolese children have hyperfiltration with co-inheritance of the HbS mutation (HbAA 6%, HbAS 16%, and HbSS 30%), 35 and we observed progressive glomerular hypertrophy in HbAS and HbSS mice. Genes implicated in hemoglobin, heme, and iron metabolism (HbA-A2, HMOX1, and SLC25A37) were also upregulated with the HbS mutation. These candidate genes have been implicated in hypertensive nephropathy (HbA-A2) 36 and sickle cell nephropathy (HMOX1), 37, 38 and play critical roles in cell-free heme and iron metabolism (HMOX1, SLC25A37). 39, 40 HbA-A2 is expressed in arterial endothelial cells and interacts with eNOS to regulate blood vessel tone. 41 Upregulation of HbA-A2, as was observed in the kidney cortex of HbAS and HbSS mice, may lead to reduced NO diffusion across the vessel wall and to increased arterial reactivity in response to adrenergic agonists such as phenylephrine. Two genes involved in electrolyte and acid-base balance, SLC4A1 and AQP6, were also differentially expressed with the HbS mutation. SLC4A1 functions as a chloride/bicarbonate exchange and mutations in SLC4A1 have been implicated in distal renal tubular acidosis 42, 43 and in hemolytic anemias.
44
AQP6 encodes an intracellular transmembrane protein involved in anion transport, including nitrate, as well as urea and glycerol, and has proposed functions in glomerular filtration, tubular endocytosis, and acid-base regulation. 45, 46 Genes implicated in the innate immune system (RSAD2), complement system activation (C3), and immune antigen processing (UBE2O) were also upregulated in the kidneys of HbAS and HbSS mice. These genes are also particularly interesting because progressive membranoproliferative glomerulonephritislike lesions, which can be associated with immunecomplex or C3 deposition, were observed in the HbAS and HbSS mice by TEM, and C3 deposition has been previously described in the GBM and mesangium of HbSS patients in some studies. 9, 10, [47] [48] [49] [50] FASN is involved in fatty acid metabolism and is upregulated under high glycemic conditions or in chronic renal failure. 51, 52 Increased expression of FASN is associated with extracellular matrix deposition 52 and we observed mesangial expansion in the HbAS and HbSS mice. In addition to these candidate genes, other genes that have been implicated in focal segmental glomerulosclerosis (PODXL) 53 and diabetic nephropathy (ELMO1 and FRMD3) 54, 55 were differentially expressed in HbAS and HbSS mice.
APOL1 is only present in some primates and humans and evolved to confer immunity against Trypanosoma brucei rhodesiense infection.
56 MYH9 co-segregates with APOL1, and risk variants in both MYH9 and APOL1 have been implicated in sickle cell nephropathy. 57 MYH9 may play a role in maintaining capillary wall integrity against hydraulic pressure and contribute to podocyte foot process retraction under pathologic conditions, and we observed increased MYH9 expression in the kidney cortex of HbAS and HbSS mice. 29, 58 APOA1 promotes oxidant scavenging and is a major structural protein of the APOL1-HDL trypanosome lytic factor. 59 We observed lower APOA1 expression in the kidney cortex of HbAS and HbSS mice.
Hypoxia hallmark genes that were differentially expressed with the HbS mutation included genes involved in glucose metabolism (GCK), maintenance of the actin cytoskeleton (SDC3), cell senescence and apoptosis (ETS1, BCL2), endothelial cell migration and angiogenesis (VEGF), and iron metabolism (CP). VEGF stimulates endothelial cell proliferation and increases vascular permeability. 60 Increased VEGF expression has been observed in the kidneys of human and animal diabetic models and has been implicated in glomerular and tubular hypertrophy in response to nephron loss. 61 Ceruloplasmin is a ferroxidase that facilitates the transport of iron across cell membranes and has both antioxidant and prooxidant properties. 62 Increased urine concentrations of ceruloplasmin have been identified as biomarkers of early glomerular disease in diabetes 63 and correlate with kidney disease stage in HbSS adults. 64 Future studies investigating expression patterns and polymorphisms in these candidate genes may improve our understanding behind the mechanisms and susceptibilities for CKD in sickle cell trait and sickle cell anemia.
We also conducted a gene set enrichment analysis from the genes that were differentially expressed in HbAS and HbSS mice and identified 3 major pathways: focal adhesion, extracellular matrix-receptor interaction, and axon guidance. Focal adhesion of sickled red blood cells can lead to ischemia-reperfusion injury with the generation of reactive oxygen species. 65 Consistent with increased oxidative stress occurring in HbAS and HbSS kidneys, significantly higher advanced oxidation protein products have been observed in the kidneys of HbAS and HbSS mice compared to HbAA mice. 66 Extracellular matrix-receptor interactions are involved in anchoring cells to the extracellular matrix and basement membrane. Interestingly, we observed glomerular basement membrane reduplication with mesangial interposition in HbAS and HbSS mice. Axon guidance plays an integral role in cell migration and differentiation, and this pathway is disrupted after ischemiareperfusion injury in the kidneys. 67 These pathways all represent biologically feasible mechanisms for kidney damage in sickle cell trait and sickle cell anemia and may represent targets for therapies to prevent CKD and improve kidney function.
In conclusion, we provide evidence of progressive glomerular and tubular damage occurring in the kidneys of transgenic mice with HbAS and HbSS supporting recent epidemiologic data that HbAS is associated with kidney disease. We have also identified several candidate genes and pathways that may be implicated in sickle cell trait and sickle cell anemia-related CKD. Our model is limited by using transgenic mice, although we observed similar pathologic lesions to what has been demonstrated in patients. Future studies confirming the histopathologic and ultrastructural lesions in people with sickle cell trait and evaluating the role of these candidate genes and pathways in sickle cell trait and sickle cell anemia-related nephropathy will provide valuable pathophysiological information and guide the development of future therapies.
